Entering the Australian Market: How Non-Resident Supplement Brands Can Navigate TGA Registration

Australia represents one of the most attractive dietary supplement markets in the Asia-Pacific region — health-conscious consumers, high disposable income, and a regulatory framework that, while strict, is transparent and navigable once you understand the architecture. For brands based outside Australia looking to manufacture through a Chinese OEM/ODM partner like Dongying Zuoning Biotechnology, the key question is always the same: How do we legally get our products registered with the Therapeutic Goods Administration (TGA)?

Understanding the TGA Framework

The TGA regulates complementary medicines under the Therapeutic Goods Act 1989. Unlike the U.S. FDA’s DSHEA framework — where supplements are treated as a category of food — Australia treats listed complementary medicines as therapeutic goods. This means higher scrutiny, but also higher consumer trust and the ability to make low-level health claims on packaging.

Most dietary supplements fall under one of two pathways:

• Listed medicines (AUST L): Lower-risk products containing pre-approved ingredients. This is the most common pathway for vitamins, minerals, herbal supplements, and sports nutrition products.
• Registered medicines (AUST R): Higher-risk products requiring full safety and efficacy evaluation. Rarely needed for standard dietary supplements unless making significant therapeutic claims.

For the majority of OEM clients we work with, the AUST L Listed Medicine pathway is the correct route.

The Non-Resident Challenge

Here is where many international brands stumble: TGA requires an Australian sponsor. The sponsor is the legal entity responsible for the product in Australia — they hold the listing, maintain post-market compliance, and serve as the TGA’s primary contact point.

If you are a U.S., European, or Asian brand without an Australian entity, you have three options:

1. Appoint an Australian sponsor/distributor: Many brands partner with an Australian distributor who acts as the sponsor. This is the most common approach but requires careful contract negotiation regarding ownership of the listing.
2. Establish an Australian subsidiary: Setting up a Pty Ltd company in Australia is straightforward and gives you full control. However, you still need a resident director (ASIC requirement) and a physical Australian business address.
3. Use a regulatory consultancy as sponsor: Some regulatory affairs firms in Australia offer sponsor services. This gives you professional compliance management without giving up commercial control to a distributor.

Important: Whichever route you choose, clarify listing ownership upfront. If a distributor sponsors the listing and the relationship ends, you may find that your product registration — and the market access it provides — belongs to them, not you.

Step-by-Step: The AUST L Listing Process

1. Confirm Ingredient Eligibility

Before investing in formulation, verify that every active ingredient in your product appears on the TGA’s Permitted Ingredients List. This list specifies:

• Maximum daily doses
• Required warning statements
• Permitted dosage forms
• Any conditions of use

If an ingredient is not on the permitted list, you will need to submit a new ingredient application, which is a significantly longer and more expensive process. At Zuoning, we pre-screen formulations against the TGA permitted list before production begins to avoid this scenario.

2. Develop the Formula with TGA Compliance in Mind

This is where your OEM partner’s experience matters. TGA-permitted ingredients sometimes differ from what is allowable under FDA or EFSA regulations. For example:

• Certain botanical extracts permitted in the U.S. may not be on the Australian list
• Maximum vitamin and mineral doses in Australia can be lower than U.S. limits
• Some excipients approved in other markets may not be permitted in listed medicines

Working with an OEM that understands these differences saves months of reformulation later.

3. Prepare Product Documentation

The TGA listing application requires:

• Product details: Name, dosage form, route of administration, target population
• Formulation table: All active and excipient ingredients with quantities and roles
• Label artwork: Compliant with TGO 92 (label formatting requirements)
• Manufacturing details: GMP certification of the manufacturer
• Evidence matrix: Scientific evidence supporting any health claims

4. GMP Certification — The Non-Negotiable

TGA requires that all listed medicines be manufactured in a TGA-recognized GMP facility. This is critical for non-resident brands: your Chinese OEM must hold a GMP certificate that TGA accepts.

China’s NMPA (formerly CFDA) GMP certification is not automatically recognized by TGA. However, TGA has mutual recognition agreements (MRAs) and compliance cooperation with several regulatory bodies. In practice, the most reliable path is to work with a manufacturer that holds one of the following:

• PIC/S GMP certification — TGA is a founding member of PIC/S, and certification from a PIC/S-participating authority is recognized
• TGA direct audit certification — TGA can audit overseas manufacturers directly, though this is more expensive and time-consuming
• ISO 22000 / HACCP — relevant for food-type supplements but not sufficient for listed medicines

At Zuoning, our manufacturing facility operates under strict GMP protocols aligned with international standards, and we assist clients in preparing the documentation TGA needs for manufacturing site verification.

5. Submit via TGA Business Services

The actual listing application is submitted online through the TGA Business Services portal. The Australian sponsor must hold an account. The system uses a risk-based self-assessment model — for AUST L medicines, the TGA does not individually evaluate every application before listing. Instead, the sponsor self-certifies compliance, and TGA conducts post-market monitoring and audits.

Do not let the self-assessment model give you false confidence. TGA’s post-market compliance program is rigorous, and non-compliant products face recall, fines, and listing cancellation. Accuracy at submission is essential.

TGA Health Claims: What You Can and Cannot Say

Australia uses a list-based system for permitted claims on listed complementary medicines:

• Permitted indications: Pre-approved low-level claims (e.g., “supports immune system function,” “helps maintain healthy bones”). These do not require individual clinical evidence if the ingredient-dose combination qualifies.
• Restricted indications: Higher-level claims that require specific evidence and may push the product into AUST R territory.
• Prohibited claims: Claims about treating serious diseases (cancer, cardiovascular disease, mental illness) are not permitted on listed medicines.

Plan your label claims before finalizing the formula. If a specific claim is central to your marketing proposition, confirm the ingredient and dose required to make that claim before manufacturing begins.

Common Pitfalls for Non-Resident Brands

• Assuming FDA compliance equals TGA compliance: It does not. Different ingredient lists, different dose limits, different claim frameworks.
• Negotiating distributor terms without protecting listing ownership: Always specify who owns the AUST L listing and what happens if the distribution agreement ends.
• Choosing an OEM without PIC/S-aligned GMP: Without acceptable GMP certification, your product cannot be listed — no exceptions.
• Underestimating label compliance (TGO 92): Label formatting, warning statements, and ingredient disclosure requirements are specific and enforced.
• Skipping the evidence file: Even for self-assessed listings, you must maintain an evidence dossier. TGA can request it at any time during post-market review.

How Zuoning Supports Your Australian Market Entry

As an experienced OEM/ODM manufacturer, we help brands navigate the Australian regulatory landscape by:

• Pre-screening formulations against the TGA Permitted Ingredients List
• Providing comprehensive manufacturing documentation for TGA submissions
• Advising on dosage form selection (capsules, tablets, powders) compatible with AUST L requirements
• Coordinating with Australian regulatory consultants when needed
• Ensuring batch-to-batch consistency for post-market compliance

The Australian market rewards brands that invest in getting compliance right the first time. With the right OEM partner and a clear understanding of TGA requirements, non-resident brands can successfully — and legally — enter one of the most trusted supplement markets in the world.

Ready to discuss your Australian market entry? Contact our team:

📧 Wade@zuoningbio.com
📞 +86 187 5469 6289
🌐 www.zuoningbio.com

Dongying Zuoning Biotechnology Co., Ltd. — Your trusted dietary supplement OEM/ODM partner in China.